Assessing Xeris Biopharma Holdings (XERS) Valuation After Strong Recent Shareholder Returns [Yahoo! Finance]
Xeris Biopharma Holdings, Inc. (XERS)
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
See our latest analysis for Xeris Biopharma Holdings. That recent 14.3% 30 day share price return sits alongside a 7.9% year to date share price gain, while the 1 year total shareholder return of 133.2% and very large 3 year total shareholder return suggest momentum has been building rather than fading around Xeris Biopharma Holdings at a share price of US$7.93. If this kind of move in biopharma has your attention, it could be a good moment to scan wider across healthcare stocks for other healthcare names catching investors' interest. With the share price at US$7.93, a value score of 3 and an implied discount to the average analyst price target, the question is whether Xeris is still undervalued or if markets are already pricing in future growth. With Xeris Biopharma Holdings last closing at US$7.93 against a narrative fair value of US$11.50, followers of this view see a sizeable valuation gap worth understanding in detail. The impending launch of XP-8121, which utilizes pr
Show less
Read more
Impact Snapshot
Event Time:
XERS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XERS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XERS alerts
High impacting Xeris Biopharma Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
XERS
News
- Is It Too Late To Consider Xeris Biopharma Holdings (XERS) After Its 133% One-Year Surge? [Yahoo! Finance]Yahoo! Finance
- Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents [Yahoo! Finance]Yahoo! Finance
- Xeris Biopharma (NASDAQ:XERS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
- Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue [Yahoo! Finance]Yahoo! Finance
- Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total RevenueBusiness Wire
XERS
Earnings
- 11/6/25 - Miss
XERS
Sec Filings
- 1/9/26 - Form 4
- 1/8/26 - Form 144
- 1/8/26 - Form 8-K
- XERS's page on the SEC website